Aimed Alliance Comments on CMS’s 340B Proposed Rule
On September 11, 2023, Aimed Alliance sent a letter to Centers for Medicare and Medicaid Services (CMS) commenting on CMS’s…
Browsing: Aimed Activity
Aimed Alliance Submits Comment on PA Benchmark Plan
On September 1, 2023, Aimed Alliance submitted a comment to Pennsylvania Insurance Commissioner request for information on the PA Benchmark…
New Survey for Employer Sponsored Health Plans
Aimed Alliance and the Alliance for Patient Access are conducting a survey with HR.com to better understand how employers view…
Aimed Alliance August Newsletter Available Now
On August 31, 2023, Aimed Alliance released its August 2023 Newsletter. This issue of Aimed Monthly includes includes an op-ed,…
Congress Requests Information on Regulation of CBD
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
New Resources Support Individuals with Growth Hormone Deficiency
English and Spanish materials include information on growth hormone deficiency symptoms, diagnosis, treatment, and health insurance appeals. WASHINGTON, DC /…
Groups File Amicus Brief to Shed Light on Harmful Drug Sourcing Tactics
WASHINGTON, DC / ACCESSWIRE / August 25, 2023 / Twenty-four organizations representing health care consumers and providers have filed an…
Advocacy Organizations Send Letter to Payer Matrix Regarding Its Identification as a “Patient Advocacy” Company
On August 17, 2023, thirty-four organizations sent a letter to Payer Matrix urging it to stop self-identifying as a “patient…
Aimed Alliance’s New Resources on CBD Regulation and Labeling
On Aug. 16, Aimed Alliance published two new resources addressing critical aspects of cannabidiol (CBD) regulation. The Food and Drug…
CONOZCA SUS DERECHOS: Deficiencia de la hormona del crecimiento
Nueva alerta de recursos — CONOZCA SUS DERECHOS: Deficiencia de la hormona del crecimiento La deficiencia de la hormona del…